Healcisio has received the prestigious Rapid Acceleration of Diagnostics (RADx Tech) Award from the NIH for its innovative KIDMATCH technology. KIDMATCH supports physicians and patients by enabling accurate differentiation of Kawasaki disease and Multisystem Inflammatory Syndrome in Children (MIS-C). The $400,000 award will enable Healcisio to scale this technology and further improve outcomes among pediatric patients.